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Accurate patient identification is an essential requirement for safe, 
continuous medical care. In low- and middle-income settings, 
multiple unrelated patient identifiers and folder numbers are 
frequently used within different health facilities and across different 
health information systems, including primary healthcare clinics, 
hospitals, pharmacies and laboratories. The introduction of a unique 
healthcare identification number is often proposed as the most 
efficient way of connecting a patient with their medical records, 
thus reducing inefficiencies and errors, saving costs and facilitating 
monitoring of national health programmes. 
South Africa (SA)’s National Department of Health has developed 
a Health Patient Registration System (HPRS) for the creation and 
allocation of a unique patient identification number for all patients 
seen in the public health sector, although it has yet to become 
operational across the country. The first step in the implementation 
of the HPRS is to register primary patient identifiers within 
the system and link these to the HPRS-created unique patient 
identification number (also referred to as the Master Patient Index 
(MPI)), and thereafter to link electronic health records. The national 
SA identification number and alternative positive identification 
numbers from official documentation (e.g. asylum seeker permits 
and passports) are being used as the primary patient identifiers in 
the HPRS (M Wolmarans, chief director, Strategic Planning, National 
Department of Health – personal communication, March 2017). 
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Background. Currently there is no unique patient identification system in the South African public health sector. Therefore, routine 
laboratory data cannot effectively be de-duplicated, thereby hampering surveillance of laboratory-diagnosed diseases such as mother-to-
child transmission of HIV. 
Objectives. To determine the uptake of Road to Health booklet (RTHB) identifiers at HIV polymerase chain reaction (PCR) birth test and 
describe their performance in linking follow-up test results in the early infant diagnosis programme.
Methods. Between May 2016 and May 2017, Tshwane District Clinical Services implemented a unique patient identifier pilot project 
in which a sticker-page of unique, readable, barcoded patient identifiers was incorporated in the patient-retained immunisation record 
(the RTHB) before distribution. Uptake of RTHB identifiers at birth was calculated as the proportion of HIV PCR tests in infants aged <6 days 
registered with an RTHB identifier over the total number of registered HIV PCR tests. Descriptive analysis of demographic details was 
performed among infants with two registered HIV PCR tests linked by the RTHB identifier, and performance of the National Health 
Laboratory Service Corporate Data Warehouse (NHLS CDW)-linking algorithm in matching RTHB-linked results was calculated using a 
2 × 2 table.
Results. A total of 5 309 HIV PCR birth tests registered with an RTHB identifier were extracted from the NHLS CDW over the 13-month 
period of the pilot project. The number of registered RTHB identifiers increased from 24 (2% of birth PCR tests) in May 2016, peaking at 
728 (56% of birth PCR tests) in May 2017. Among infants with a registered RTHB identifier at birth, 635 (12%) had a subsequent linked HIV 
PCR test, as indicated by the same RTHB number registered for a later specimen. Demographic details at the time of birth and subsequent 
PCR test were compared, demonstrating that <4% of infants had exact matches for name, surname, date of birth and sex; 74% of birth tests 
had variations such as ‘born to’ or ‘baby of ’ in place of a first name; surnames matched exactly in 61% of cases; 18% (n=116) of infants had 
both tests performed at the same facility, of which only 27% (n=31) had the same patient folder number on both test results.
Conclusions. Leveraging RTHBs as unique patient identifiers, even if used temporarily until linkage to other future national unique 
identifiers, promises to be an effective scalable approach to laboratory-based surveillance, facilitating healthcare provider access to all test 
results from birth. 
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This raises several important questions regarding the ability of the 
HPRS to assist with national disease surveillance, especially within 
programmes that monitor disease incidence among newborn infants, 
such as the prevention of mother-to-child transmission (PMTCT) 
of HIV programme (which monitors and acts on infant HIV test 
results from birth). The infrastructural requirements needed to 
generate national identity numbers for all newborn infants, and 
parental indecision regarding a newborn’s name and surname, are 
likely to delay registration and assignment of a national identity 
number prior to discharge. Furthermore, in healthcare settings with 
a high proportion of migrants, use of national identity numbers as 
a requirement for access to healthcare can represent an important 
obstacle towards achieving equity in the healthcare system. Even 
if MPIs were to be provided without identification numbers, it is 
unclear how these could be generated before neonatal testing at all 
obstetric units across the country.
In contrast to national identification number documents, infant 
immunisation records are readily available at birth and handed to 
each mother at the time of delivery, regardless of race, ethnicity, 
nationality or health facility. Furthermore, they are free of cost 
and have the potential to play an important role in tracking and 
documenting immunisation status and other childhood health 
services received.[1] They are therefore well positioned to be leveraged 
as a vehicle to provide newborn infants with a unique patient 
identifier. In SA, the patient-retained immunisation record, referred 
to as the Road to Health booklet (RTHB), is a comprehensive child 
health document that includes health-promotion information, as well 
as growth and developmental monitoring tools and the ability to track 
adherence to the PMTCT programme. Early infant diagnosis (EID) 
of HIV, an essential component of the PMTCT programme, includes 
routine HIV polymerase chain reaction (PCR) testing at birth and 
10 weeks of age for all HIV-exposed infants – ~260 000 infants per 
annum in SA.[2] Hence, the RTHB has a pivotal role in improving 
communication between health workers and caregivers, empowering 
caregivers, enhancing continuity and co-ordination of care, as well 
as having the potential to assist with monitoring of national public 
health programmes, such as the PMTCT programme.[3] Although 
the World Health Organization (WHO) recommends that patient-
held immunisation records be issued with a unique identifier,[1] SA’s 
RTHBs are currently not issued with identifiers, despite being printed 
and distributed centrally.
In May 2016, Tshwane District Clinical Services implemented 
a unique patient identifier pilot project in which unique, readable 
barcoded patient identifiers were incorporated in the RTHBs and 
distributed within the district. We report on the use of these 
identifiers and describe their performance in linking follow-up test 
results within the HIV EID programme.
Methods
Setting
Tshwane District is a large metropolitan area in SA’s Gauteng 
Province. There are ~50  000 live births per annum in the district’s 
public health sector; 12  000 (24%) of these infants are born to 
HIV-infected mothers (L Bamford, National Department of Health 
– personal communication, July 2017). National guidelines for EID 
recommend that all HIV-exposed infants have routine HIV PCR 
testing at birth, at 10 weeks of age and 6 weeks after cessation of 
breastfeeding, with confirmatory testing of infants who test positive 
or indeterminate using the same assay on a subsequent specimen.[4,5] 
On account of this, and the lack of a national unique patient identifier, 
routine laboratory data cannot effectively be de-duplicated, thereby 
hampering surveillance efforts, such as estimating mother-to-child 
transmission rates. To address these challenges, various probabilistic 
patient-linking algorithms are used that employ demographic details, 
including first name, surname, sex and date of birth, to link all 
laboratory results to an individual patient. The algorithm currently 
used by the National Health Laboratory Service Corporate Data 
Warehouse (NHLS CDW) has a reported sensitivity of 73% and 
positive predictive value of 83% among adult patients,[6] while 
performance among infants is unknown. 
Road to Health booklet identifiers
The RTHB is a standardised patient-retained health record issued at 
birth to all infants born in the SA public health sector, and documents 
an infant’s immunisation, growth and PMTCT status. Between May 
2016 and May 2017, RTHBs distributed within Tshwane District were 
pre-issued with a unique patient identifier. To avoid stigma, these 
were issued to infants, regardless of nationality or HIV-exposure 
status. An identifier product, custom designed for the purpose of 
this pilot project, comprised a page of 30 readable barcoded stickers, 
with a separate laminated barcoded peal-out card, as well as adhesive 
strips to facilitate manual insertion in the RTHBs (Fig. 1). Initially, 
70  000 unique RTHB identifiers were printed at ZAR4.57 per 
identifier. Identifiers were prefixed with the letters RTHB, followed 
by a unique combination of four numerals and four alphas, so as 
to distinguish them from all other identifiers/barcodes used in 
the public health sector. Clinical staff working in the district were 
requested to place an RTHB sticker on the laboratory request form 
each time clinical specimens were submitted to the laboratory, and 
laboratory personnel were requested to capture the RTHB identifiers 
within a specific searchable field (alternate reference number) 
available on the laboratory information system and not currently 
used within the district. An additional column populating the RTHB 
identifiers was also incorporated in the consolidated HIV PCR results 
(Results for Action Reports) routinely distributed in the district on a 
weekly basis, thereby allowing continuous monitoring of uptake and 
usage of RTHB identifiers in all public health facilities in the district.
Analysis
All HIV PCR results taken from health facilities in Tshwane District 
and registered between 1 May 2016 and 31 May 2017 were extracted 
from the NHLS CDW. Uptake of RTHB identifiers at birth was 
calculated as the proportion of HIV PCR tests among infants aged 
<6 days, registered with an RTHB identifier over the total number of 
registered HIV PCR tests among this age group. Descriptive analysis 
was performed and median and interquartile ranges (IQRs) were 
calculated for duration between birth and subsequent testing. As a 
means of validating the performance of the NHLS patient-linking 
algorithm among newborn infants, we measured the ability of this 
linking algorithm against the RTHB unique patient identifier issued 
to link HIV PCR laboratory results at birth (defined as infants aged 
<6 days) to subsequent registered HIV PCR results. Performance of 
the NHLS CDW-linking algorithm in identifying RTHB numbers 
was calculated using 2 × 2 tables. Analysis of first names and 
surnames among RTHB-linked results was performed manually by 
a single researcher, and coded into one of three categories: names 
that were recognisably similar (with character differences counted), 
names that were considered distinctly different, and names that were 
prefixed (or followed) by an indication that the patient had yet to be 
named (e.g. ‘baby of ’ or ‘born to’). Data were extracted in Microsoft 
Excel, and all statistical analysis was performed using STATA 
version 14 (StataCorp., USA).
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Results
Among 13 499 HIV PCR birth tests extracted 
from the NHLS CDW over the 13-month 
study period, 5 309 (39%) had a registered 
RTHB identifier. The number and propor-
tion of birth tests with an RTHB identifier 
increased from 24 (2%) in May 2016 to 727 
(56%) in May 2017 (Fig. 2). Among the 
5  309 infants with an RTHB identifier 
captured at birth, 635 (12%) were found to 
have had a second HIV PCR test, as indicated 
by the same RTHB identifier registered for a 
later specimen, with 25 (0.5%) infants having 
a third test. The median age at first PCR test 
was 1 day (IQR1 - 1) and at second test 73 days 
(IQR 70 - 81). Unfortunately, the coverage 
of PCR testing after birth in the district 
is unknown on account of the inability to 
effectively de-duplicate routine laboratory 
data. However, HIV PCR testing volumes 
within Tshwane District among infants aged 
between 8 and 14 weeks approximated two-
thirds of the testing volume at birth during 
the study period. 
Of the 635 infants with ≥2 RTHB-
linked tests, birth HIV PCR results were 
as follows: 6 (0.9%) were positive, 7 (1.1%) 
indeterminate, 604 (95%) negative and 18 
(3%) rejected. Among the 6 infants with a 
positive result at birth, 5 tested positive and 
1 indeterminate on the second test, whereas 
of the 7 infants who had an indeterminate 
result at birth, 5 tested negative and 2 posi tive 
on the second test. Only 1 of the 5 infants with 
an indeterminate-negative result had a third 
HIV PCR test, which was positive. Hence, 
9 of 635 (1.4%) infants could be classified 
as having an intra-uterine infection, as 
determined by two instrument-detected 
results (i.e. either positive or indeterminate), 
of which one was a birth test. As none 
of these patients had the same facility 
number on follow-up testing and none 
could be linked using the current NHLS 
CDW patient-linking algorithm, the RTHB 
identifier proved to be the only consistent 
identifier linking these results (6 of the 9 infants 
had the same sur name registered for their 
screening and confirmatory tests, but first 
names differed for all of these patients). 
Of the 609 infants who tested negative at 
birth, 3 (0.5%) had an instrument-detected 
result on the second test (2 positive and 
1 indeterminate), which was suggestive of 
intrapartum or early postnatal infection. 
Comparing demographic details of 
the 635 birth HIV PCR tests with their 
subsequent registered HIV PCR tests, in 
only 23 (4%) infants did all four of their 
primary demographic details (viz. first 
name, surname, sex and date of birth) match 
exactly. Whereas first name matched in only 
33 (5%) cases, surname proved to be more 
consistent, with 390 (61%) exact matches, 
followed by sex in 577 (91%) cases, and 
date of birth in 579 (91%) cases. Although 
116 (18%) infants accessed the same health 
facility for follow-up testing, among these 
only 31 (5% of total) had the same facility 
folder number on repeat testing. Results 
of patients whose first name and surname 
differed were analysed further to determine 
reasons for failed matching: of the 602 infants 
whose first name did not match exactly, only 
1 (0.2%) was recognisably similar for both 
tests (with one-character difference between 
the initial and subsequent test results). In 
comparison, among 245 infants whose 
surname did not match exactly, 86 (14% of 
total) were recognisably similar, of whom 59 
(68%) had one character difference, 17 (20%) 
had two character differences, 5 (6%) had 
three character differences and an additional 
5 (6%) had four character differences. 
Among the 635 birth tests, 468 (74%) were 
registered for patients who had their first 
name prefixed by a variation of ‘baby of ’ (i.e. 
suggesting either the patient had yet to be 
named or was registered under the mother’s 
details). Even among infant surnames, the 
prefix (and occasionally suffix) ‘B/T’ or ‘BT’ 
accounted for 37 mismatches, of which 23 
had the exact same surname otherwise. 
Hence, whereas first name could only be 
matched at most in 36 (6%) of 635 cases, 
surname could potentially be matched in 
499 (79%) cases. Among the 468 infants 
whose birth test was not registered with 
their own name, 271 (58%) had exactly the 
same date of birth and surname or were 
linked using a facility folder number, and 
Figure 1. Road to Health Booklet Unique Patient Identifier 
 
 
 
 
Fig. 1. Road to Health booklet unique patient identifier.
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an additional 57 (12%) had exactly the same date of birth but the 
surname, although similar, differed by one or more characters.
Overall, 326 (51% of total) HIV PCR birth tests could be linked 
to the subsequent HIV PCR test using either the facility folder 
number or matched with the exact same surname and date of birth. 
An additional 177 (28% of total) infants could potentially be linked 
using less stringent demographic criteria, including slight differences 
of surname and/or date of birth. This leaves at least 133 (21% of 
total) infants unable to be matched using demographic and/or 
facility details. The current NHLS CDW patient-linking algorithm 
was evaluated to determine performance of linking birth tests with 
subsequent results. A total of 30 true-positive, 44 false-positive, 
4 595 true-negative and 605 false-negative patient links were made. 
Using the RTHB identifier as the gold standard, sensitivity was 
calculated at 4.7%, specificity at 99.1%, positive predictive value 
at 40.5%, negative predictive value at 88.4% and overall accuracy 
at 87.7%. Importantly, name and surname are considered part of 
the minimum clinical data set in the NHLS, without which clinical 
specimens are routinely rejected and not tested. During the study 
period, only 6 (0.1%) specimens registered with the RTHB identifier 
were rejected on account of no patient name, surname or number 
provided on the laboratory request form. 
Discussion
The proportion of HIV PCR birth tests registered with the RTHB 
identifier reached >50% after only 6 months in this proof-of-concept 
pilot project, suggesting RTHBs can successfully be leveraged to 
provide infants with a unique patient identifier at birth. The project 
further demonstrated that the RTHB identifiers can readily be 
incorporated in the laboratory information system and the NHLS 
CDW environment. This allowed individual patient results to be 
searched with the RTHB identifier, using the TrakCare Web Results 
Viewer application, with all results registered with the patient’s 
unique RTHB identifier readily retrieved using a single search. 
Furthermore, the additional column populating the RTHB identifiers 
incorporated in the consolidated weekly HIV PCR Results for Action 
Report, allowed continuous monitoring of uptake and usage of RTHB 
identifiers among all of the public health facilities in the district. 
Interestingly, the intra-uterine and intrapartum infection rates among 
the RTHB identifier cohort are similar to near-contemporaneous 
birth cohorts described in SA,[7,8] supporting the potential use of 
RTHB identifiers for EID surveillance. 
Although usage rose rapidly after the first few months of the 
project, coverage plateaued and did not exceed 56%. This can possibly 
be attributed to shortages of printed books with RTHB identifiers, 
as the printing had been sourced from alternative funding. An 
additional 10 000 books with identifiers were subsequently printed, 
thereby preventing a steeper decline in usage. Despite the successes 
of registering the birth tests with RTHB identifiers, the coverage 
of the routine 10-week HIV PCR tests proved to be markedly less. 
Only 12% of infants with a birth RTHB identifier were found to 
have a subsequent HIV PCR test with a registered RTHB identifier, 
suggesting primary healthcare clinics need to be better informed and 
motivated regarding usage of the RTHB identifiers for subsequent 
tests after birth, especially if the project is to be scaled up.
Where RTHB identifiers were consistently used, they proved 
to be very effective in linking results and far more reliable than 
demographic details and facility numbers. Even among infants who 
were followed up for their subsequent HIV PCR tests at the same 
facility as the birth test, only a quarter had the same facility number. 
Overall, three-quarters of birth tests were registered for patients 
who had their first name prefixed by a variation of ‘baby of ’ (i.e. 
suggesting either the patient had yet to be named or was registered 
under the mother’s details), 39% of surnames did not match the 
subsequent HIV PCR test, and both date of birth and sex did not 
match in 10% of cases. These findings suggest that linking laboratory 
results of infants using facility numbers and probabilistic matching 
of demographic details are inherently problematic and unreliable. In 
patients with RTHB identifiers, only 0.1% of results were rejected on 
account of missing demographic information, which suggests that the 
use of RTHB identifiers is unlikely to be associated with healthcare 
providers omitting demographic information because they now have 
a unique RTHB identifier. However, we did not conduct specific 
statistical analyses to test this, which could be considered a limitation 
of our analysis.
SA’s PMTCT programme represents just one screening programme 
that could benefit greatly from leveraging RTHB identifiers as a 
system for patient identification. The consistent use of a unique 
patient identifier from birth that is captured in the laboratory 
information system promises great advantages for patient care, as 
well as public health surveillance, planning and response. By linking 
a patient’s barcoded identifier with each registered laboratory test 
set, whether by scanning the barcode or manually entering the 
identifier in a searchable field of the laboratory information system, 
all laboratory results for an individual patient can in effect be 
retrieved using a single identifier. This could have significant cost-
saving benefits, especially for national diagnostic and monitoring 
programmes that make use of a single laboratory network, as 
unnecessary repeat testing would be reduced through ready retrieval 
of previous results. Furthermore, the use of a patient identifier that 
links clinical records with laboratory results would facilitate cohort 
monitoring. Hence, records in health information systems could 
effectively be de-duplicated, thereby enabling surveillance efforts 
that use routine data for epidemiological purposes and programme 
planning.[9] For example, this would make it possible to monitor the 
HIV infant testing coverage in different age groups and accurately 
determine overall mother-to-child transmission rates for the first 
time.
In addition to registering the RTHB identifier as an alternative 
reference number, it could be used as the patient’s folder number, 
thereby providing a ready alternative to the mother’s facility number, 
and used to link the infant’s facility-based file with the home-based 
immunisation record. The RTHB identifier could also be used to 
inform the laboratory which HIV PCR requests are for infants (as 
indicated by the RTHB identifier provided on the laboratory request 
form) as opposed to unnecessary requests for adults, and thereby 
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Fig. 2. Number and proportion of Road to Health booklet identifiers captured 
at HIV PCR birth testing during the pilot project. (PCR = polymerase chain 
reaction; RTHB = Road to Health booklet.) 
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assist with electronic gatekeeping in the NHLS. RTHB identifiers 
could also be used in the birth registry and in electronic health 
records, as well as incorporated in the MomConnect programme as a 
means of establishing a searchable link between mother-infant pairs. 
Furthermore, identifier stickers provide an opportunity to facilitate 
linking of other electronic health information systems, including the 
pharmacy and imaging department, to the laboratory records. As a 
means of addressing the difficulties in providing all newborn infants 
with their own primary patient identifier or HPRS number prior to 
neonatal testing, the RTHB identifiers could be used to bridge the 
initial period until a final unique patient identifier is issued to the child, 
thereby ensuring electronic linking of laboratory results and providing 
the opportunity for longitudinal health monitoring from birth. 
An important limitation of using patient-retained records as 
patient identifiers is the propensity for losing or forgetting these 
at the time of presenting to a healthcare facility. Indeed, current 
evidence suggests that few national health systems are able to 
retain immunisation records at levels of >80% on follow-up, despite 
distribution levels of >90% with regard to newborns.[10,11] This can 
have serious implications for patient care and limit the effectiveness of 
leveraging the RTHB as a vehicle for patient identification. Additional 
limitations include the potential costs involved in printing barcoded 
unique identifier stickers and the infrastructural requirements – in 
the health facility and clinical laboratory – to capture the unique 
patient identifiers and regenerate identifier stickers once these are 
exhausted in the RTHB. However, these concerns can readily be 
countered on the basis that the use of immunisation booklets as 
unique identifiers could again place the focus on the importance of 
home-based vaccination records, thereby improving co-ordination 
of patient-centred services and recording during immunisation 
programmes, as well as decreasing unnecessary and expensive 
re-immunisation and re-testing services.[12] Furthermore, the use of 
an additional peel-out identifier card could provide caregivers the 
opportunity to safe-keep a record of the RTHB identifier in case the 
immunisation record is lost. As barcoded stickers are inexpensive and 
technology that is readily available to ensure unique combinations is 
provided per RTHB, it is anticipated that the cost-savings associated 
with their use would justify the expense. 
Conclusions
In summary, we propose that the patient-retained immunisation 
record (i.e. the RTHB) represents an unambiguous and stigma-free 
opportunity to provide a unique identifier to all neonates at birth 
or first contact with health services. Pre-issued barcoded identifier 
stickers (with readable numeric/alphanumeric code) will assist 
with the consistent use of the RTHB identifier and reduce the 
possibility of transcription error. As the HPRS number (or MPI) is 
unlikely to be available to all newborn infants at the time of neonatal 
testing, the RTHB identifier could readily be used, with minimal 
infrastructural and cost requirements, to bridge patient identification 
during early infancy until a final unique health identifier (i.e. HPRS 
number) can be issued. This in turn will support the continuum of 
care and surveillance efforts, allowing multiple health visits to be 
electronically linked, thereby reducing inefficiencies, saving costs 
and ultimately improving care. Such an initiative has numerous 
additional advantages, including the ability to match mother-infant 
pairs. On account of substantial differences in folder numbers and 
demographic details of infants, patient-linking algorithms are unable 
to accurately match infant tests in the NHLS CDW, and at best will 
link only 70 - 80% of patient results, further highlighting the need for 
a ready alternative for infant patient identification.
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